Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Apr 19;292(6527):1033–1034. doi: 10.1136/bmj.292.6527.1033

Treatment of type II diabetes.

M Nattrass
PMCID: PMC1340103  PMID: 3083989

Full text

PDF
1033

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom A. Some practical aspects of the management of diabetes. Clin Endocrinol Metab. 1977 Jul;6(2):499–517. doi: 10.1016/s0300-595x(77)80049-2. [DOI] [PubMed] [Google Scholar]
  2. Feinglos M. N., Lebovitz H. E. Sulphonylureas increase the number of insulin receptors. Nature. 1978 Nov 9;276(5684):184–185. doi: 10.1038/276184a0. [DOI] [PubMed] [Google Scholar]
  3. Kilo C., Miller J. P., Williamson J. R. The crux of the UGDP. Spurious results and biologically inappropriate data analysis. Diabetologia. 1980 Mar;18(3):179–185. doi: 10.1007/BF00251913. [DOI] [PubMed] [Google Scholar]
  4. Maloff B. L., Lockwood D. H. In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport. J Clin Invest. 1981 Jul;68(1):85–90. doi: 10.1172/JCI110257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Nattrass M., Todd P. G., Hinks L., Lloyd B., Alberti K. G. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia. 1977 Apr;13(2):145–152. doi: 10.1007/BF00745143. [DOI] [PubMed] [Google Scholar]
  6. Olefsky J. M., Reaven G. M. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med. 1976 Jan;60(1):89–95. doi: 10.1016/0002-9343(76)90537-4. [DOI] [PubMed] [Google Scholar]
  7. Paton R. C., Kernoff P. B., Wales J. K., McNicol G. P. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics. Br Med J (Clin Res Ed) 1981 Oct 17;283(6298):1018–1020. doi: 10.1136/bmj.283.6298.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Peacock I., Tattersall R. B. The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? Br Med J (Clin Res Ed) 1984 Jun 30;288(6435):1956–1959. doi: 10.1136/bmj.288.6435.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rizza R. A., Mandarino L. J., Gerich J. E. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes. 1981 Dec;30(12):990–995. doi: 10.2337/diab.30.12.990. [DOI] [PubMed] [Google Scholar]
  10. Salhanick A. I., Konowitz P., Amatruda J. M. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats. Diabetes. 1983 Mar;32(3):206–212. doi: 10.2337/diab.32.3.206. [DOI] [PubMed] [Google Scholar]
  11. Sheldon J., Taylor K. W., Anderson J. The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes. Metabolism. 1966 Oct;15(10):874–883. doi: 10.1016/0026-0495(66)90158-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES